Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial
- PMID: 24562806
- PMCID: PMC3932776
- DOI: 10.1177/2048872613508658
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial
Abstract
Aims: ST-segment resolution (STR) after reperfusion therapy has been shown to correlate with prognosis in patients with ST-segment elevation myocardial infarction (STEMI). We investigated whether acute ECG measurements also correlate with ultimate infarct size.
Methods and results: The INFUSE-AMI trial randomized 452 patients with anterior STEMI to intracoronary bolus abciximab vs. no abciximab, and to thrombus aspiration vs. no aspiration. Infarct size as percentage of total LV mass was calculated by cardiac magnetic resonance imaging (MRI) 30 days post intervention. Five ECG methods were analysed for their ability to predict MRI infarct mass: (1) summed STR across all infarct-related ECG leads (ΣSTR); (2) STR in the single lead with maximum baseline ST-segment elevation (maxSTR); (3) summed residual ST-segment elevation across all infarct-related leads at 60 min post intervention (ΣST residual); (4) maximum residual ST-segment elevation in the worst single lead at 60 min post intervention (maxST residual); (5) number of new significant Q-waves (Qwave) at 60 min. All ECG methods strongly correlated with 30-day MRI infarct mass (all p<0.003). Simpler ECG measurements such as maxSTresidual and Qwave were as predictive as more complex measurements. A subset analysis of 158 patients who had microvascular obstruction (MVO) determined by MRI 5 days post intervention also showed strong correlations of MVO with the ECG measures.
Conclusions: ST-segment and Q-wave changes after primary PCI in anterior STEMI strongly correlated with 30-day infarct size by MRI. In particular, maxST residual and Qwave at 60 min are simple ECG parameters that offer rapid analysis for prognostication.
Keywords: Cardiac magnetic resonance imaging; ST elevation myocardial infarction; ST-segment resolution; electrocardiogram.
Conflict of interest statement
Figures
Similar articles
-
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.JACC Cardiovasc Interv. 2013 Jul;6(7):718-24. doi: 10.1016/j.jcin.2013.03.013. JACC Cardiovasc Interv. 2013. PMID: 23866184 Clinical Trial.
-
Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.Am Heart J. 2013 Jul;166(1):64-70. doi: 10.1016/j.ahj.2013.03.029. Epub 2013 Apr 30. Am Heart J. 2013. PMID: 23816023 Clinical Trial.
-
Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction.Am Heart J. 2011 Mar;161(3):478-486.e7. doi: 10.1016/j.ahj.2010.10.006. Epub 2011 Jan 28. Am Heart J. 2011. PMID: 21392601 Clinical Trial.
-
Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.Am J Cardiol. 2012 Mar 1;109(5):624-8. doi: 10.1016/j.amjcard.2011.10.016. Epub 2011 Dec 5. Am J Cardiol. 2012. PMID: 22152971 Review.
-
Intracoronary injection of glycoprotein IIb/IIIa, abciximab, as adjuvant therapy in primary coronary intervention.Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):89-95. doi: 10.2174/1871525711311020003. Cardiovasc Hematol Agents Med Chem. 2013. PMID: 23394547 Review.
Cited by
-
Study on Correlation between Type 2 Diabetes and No-Reflow after PCI.Dis Markers. 2022 Mar 17;2022:7319277. doi: 10.1155/2022/7319277. eCollection 2022. Dis Markers. 2022. PMID: 35340412 Free PMC article.
-
Biomarkers in acute myocardial infarction: current perspectives.Vasc Health Risk Manag. 2019 Jan 17;15:1-10. doi: 10.2147/VHRM.S166157. eCollection 2019. Vasc Health Risk Manag. 2019. PMID: 30697054 Free PMC article. Review.
-
Impact of Early ST-Segment Changes on Cardiac Magnetic Resonance-Verified Intramyocardial Haemorrhage and Microvascular Obstruction in ST-Elevation Myocardial Infarction Patients.Medicine (Baltimore). 2015 Sep;94(35):e1438. doi: 10.1097/MD.0000000000001438. Medicine (Baltimore). 2015. PMID: 26334905 Free PMC article.
-
Clinical predictors of left ventricular thrombus after myocardial infarction as detected by magnetic resonance imaging.Front Cardiovasc Med. 2024 Jan 16;10:1275390. doi: 10.3389/fcvm.2023.1275390. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38292454 Free PMC article.
-
Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study.Basic Res Cardiol. 2021 Jul 19;116(1):45. doi: 10.1007/s00395-021-00884-6. Basic Res Cardiol. 2021. PMID: 34279726 Clinical Trial.
References
-
- Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index:prospective cohort study. Heart 2008; 94: 730–736 - PubMed
-
- Hallen J, Buser P, Schwitter J, et al. Relation of cardiac troponin I measurement at 24 and 48 hours to magnetic resonance-determined infarct size in patients with ST-elevation myocardial infarction. Am J Cardiol 2009; 104: 1472–1477 - PubMed
-
- Klug G, Mayr A, Mair J, et al. Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI. Clin Res Cardiol 2011; 100: 501–510 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous